Lozano, R, Castro, E, -Campos, FL, Thorne, H, Ramirez-Backhaus, M, Aragon, IM, Cendon-Florez, Y, Gutierrez-Pecharroman, A, Salles, DC, Romero-Laorden, N, Lorente, D, Gonzalez-Peramato, P, Calatrava, A, Alonso, C, Anido, U, Arevalo-Lobera, S, Balmana, J, Chirivella, I, Juan-Fita, MJ, Llort, G, Cajal, TRY, Almagro, E, Alameda, D, Lopez-Casas, PP, Herrera, B, Mateo, J, Pritchard, CC, Antonarakis, ES, Lotan, TL, Rubio-Briones, J, Sandhu, S, Olmos, D. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. EUROPEAN JOURNAL OF CANCER. 2023; 185DOI:10.1016/j.ejca.2023.02.022. PMID:36972661. IF:7.600(Q1/2D).

Sanfilippo, R, Hindi, N, Jurado, JC, Blay, JY, Lopez-Pousa, A, Italiano, A, Alvarez, R, Gutierrez, A, Rincon-Perez, I, Sangalli, C, Aguiar, JLP, Romero, J, Morosi, C, Sunyach, MP, Fabbroni, C, Romagosa, C, Ranchere-Vince, D, Dei Tos, AP, Casali, PG, Martin-Broto, J, Gronchi, A. Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma A Nonrandomized Clinical Trial. JAMA Oncology. 2023; 9(5)DOI:10.1001/jamaoncol.2023.0056. PMID:36995731. IF:22.300(Q1/1D).

Martinez-Bosch, N, Vilarino, N, Alameda, F, Mojal, S, Arumi-Uria, M, Carrato, C, Aldecoa, I, Ribalta, T, Vidal, N, Bellosillo, B, Menendez, S, Del Barco, S, Gallego, O, Pineda, E, Lopez-Martos, R, Hernandez, A, Mesia, C, Esteve-Codina, A, de la Iglesia, N, Balana, C, Martinez-Garcia, M, Navarro, P. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker. Cells. 2023; 12(6)DOI:10.3390/cells12060843. PMID:36980184. IF:5.100(Q2/4D).

Chmielecki, J, Gray, JE, Cheng, Y, Ohe, Y, Imamura, F, Cho, BC, Lin, MC, Majem, M, Shah, R, Rukazenkov, Y, Todd, A, Markovets, A, Barrett, JC, Hartmaier, RJ, Ramalingam, SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-35961-y. PMID:36849494. IF:14.700(Q1/1D).